|
|
|
Insider
Information: |
Barrett M James |
Relationship: |
10% Owner |
City: |
Baltimore |
State: |
MD |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
45 |
|
Direct
Shares |
1,977,383 |
|
Indirect Shares
|
257,297,662 |
|
|
Direct
Value |
$26,346,729 |
|
|
Indirect Value
|
$737,967,397 |
|
|
Total
Shares |
259,275,045 |
|
|
Total
Value |
$764,314,127 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
3
|
Stock
price went up :
|
0
|
2
|
Stock
price went down : |
0
|
1
|
|
|
|
Gain/Loss Ratio : |
0.0
|
2.0
|
Percentage
Gain/Loss : |
0.0%
|
-49.2%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Welltek Incorporated |
WTKND |
Director |
2008-03-07 |
0 |
2008-03-07 |
0 |
Premium* |
|
Aradigm Corp |
ARDM |
10% Owner |
2003-12-11 |
2,905 |
2003-12-11 |
0 |
Premium* |
|
Gyre Therapeutics |
GYRE |
10% Owner |
2013-12-03 |
0 |
2013-12-05 |
4,563,512 |
Premium* |
|
Paratek Pharmaceuticals Inc |
PRTK |
10% Owner |
2006-05-15 |
0 |
2009-01-30 |
2,083,426 |
Premium* |
|
Vonage Holdings Corp |
VG |
10% Owner |
2006-05-30 |
0 |
2011-03-11 |
22,793 |
Premium* |
|
Innerworkings Inc |
INWK |
10% Owner |
2007-12-11 |
0 |
2012-03-28 |
15,000 |
Premium* |
|
Medimmune Inc |
MEDI |
Director |
2007-06-18 |
0 |
2007-06-18 |
0 |
Premium* |
|
Echo Global Logistics Inc |
ECHO |
10% Owner |
2012-02-29 |
0 |
2012-02-28 |
0 |
Premium* |
|
Groupon, Inc. |
GRPN |
10% Owner |
2013-09-13 |
5,918 |
2013-09-13 |
41,260 |
Premium* |
|
Clovis Oncology, Inc. |
CLVS |
Director |
2017-02-27 |
861 |
2017-02-27 |
861 |
Premium* |
|
Amicus Therapeutics Inc |
FOLD |
Director, 10% Owner |
2012-03-07 |
0 |
2012-03-07 |
4,584,311 |
Premium* |
|
Millennial Media Inc |
MM |
10% Owner |
2012-04-03 |
0 |
2012-10-29 |
8,196,614 |
Premium* |
|
Tesaro, Inc. |
TSRO |
10% Owner |
2018-03-06 |
252 |
2018-03-06 |
9,681,381 |
Premium* |
|
Hyperion Therapeutics Inc |
HPTX |
10% Owner |
2014-06-06 |
0 |
2015-05-07 |
0 |
Premium* |
|
Audience Inc |
ADNC |
10% Owner |
2013-11-04 |
508 |
2013-11-05 |
0 |
Premium* |
|
Workday, Inc. |
WDAY |
10% Owner |
2013-04-10 |
1,273 |
2013-04-10 |
10,396 |
Premium* |
|
Tableau Software Inc |
DATA |
10% Owner |
2014-12-02 |
20,522 |
2014-12-02 |
69,572 |
Premium* |
|
Interleukin Genetics Inc |
ILIU |
10% Owner |
|
0 |
2016-07-29 |
55,418,811 |
Premium* |
|
Epizyme, Inc. |
EPZM |
10% Owner |
2014-08-15 |
0 |
2016-01-12 |
6,260,851 |
Premium* |
|
Boingo Wireless Inc |
WIFI |
10% Owner |
2013-12-11 |
0 |
2013-12-11 |
0 |
Premium* |
|
Glycomimetics Inc |
GLYC |
Director, 10% Owner |
|
0 |
2018-05-10 |
9,089,041 |
Premium* |
|
Care.com Inc |
CRCM |
10% Owner |
2017-11-06 |
252 |
2017-11-06 |
252 |
Premium* |
|
Roka Bioscience, Inc. |
ROKA |
Director, 10% Owner |
|
0 |
2014-07-22 |
3,216,810 |
Premium* |
|
Loxo Oncology, Inc. |
LOXO |
Director, 10% Owner |
2014-08-06 |
0 |
2014-08-06 |
1,789,420 |
Premium* |
|
Viracta Therapeutics Ord Shs |
VIRX |
10% Owner |
2014-08-08 |
0 |
2014-08-29 |
4,659,333 |
Premium* |
|
Ardelyx Inc |
ARDX |
10% Owner |
2014-12-26 |
0 |
2018-05-25 |
9,169,210 |
Premium* |
|
Box Inc |
BOX |
10% Owner |
|
0 |
2015-01-28 |
0 |
Premium* |
|
Zosano Pharma Corp |
ZSAN |
10% Owner |
2017-02-13 |
5 |
2017-02-13 |
952,809 |
Premium* |
|
Tracon Pharmaceuticals, Inc. |
TCON |
10% Owner |
2015-02-04 |
0 |
2016-11-29 |
2,758,039 |
Premium* |
|
Champions Biotechnology Inc |
CSBR |
10% Owner |
|
0 |
2015-03-11 |
18,750,000 |
Premium* |
|
Supernus Pharmaceuticals Inc |
SUPN |
Director |
2016-03-16 |
97,355 |
2016-03-16 |
115,355 |
Premium* |
|
Vitae Pharmaceuticals, Inc |
VTAE |
10% Owner |
2015-07-01 |
464 |
2015-07-01 |
1,134 |
Premium* |
|
Synlogic Inc |
SYBX |
10% Owner |
2015-10-05 |
0 |
2018-01-26 |
4,228,940 |
Premium* |
|
Avalo Therapeutics, Inc |
AVTX |
10% Owner |
2015-10-20 |
0 |
2015-10-20 |
594,245 |
Premium* |
|
Adaptimmune Therapeutics PLC |
ADAP |
10% Owner |
|
0 |
2018-09-07 |
82,978,668 |
Premium* |
|
Kineta Ord Shs |
KA |
Director, 10% Owner |
2016-02-17 |
0 |
2017-12-18 |
5,554,610 |
Premium* |
|
Senseonics Holdings Inc |
SENS |
Director |
2019-01-02 |
512,720 |
2019-01-02 |
152,079 |
Premium* |
|
Ra Pharmaceuticals, Inc. |
RARX |
10% Owner |
2016-10-31 |
0 |
2016-10-31 |
3,490,073 |
Premium* |
|
Mulesoft, Inc |
MULE |
10% Owner |
|
0 |
2018-05-01 |
0 |
Premium* |
|
Mersana Therapeutics, Inc. |
MRSN |
10% Owner |
2017-07-03 |
0 |
2017-07-03 |
8,140,138 |
Premium* |
|
Surface Oncology, Inc. |
SURF |
10% Owner |
2018-04-23 |
0 |
2018-04-23 |
3,312,877 |
Premium* |
|
Rhythm Pharmaceuticals, Inc. |
RYTM |
10% Owner |
2017-10-10 |
0 |
2017-10-10 |
4,909,956 |
Premium* |
|
Appian Corp |
APPN |
10% Owner |
2018-02-13 |
1,015 |
2018-02-13 |
1,015 |
Premium* |
|
Bloom Energy Corp |
BE |
10% Owner |
2018-07-27 |
1,333,333 |
2018-07-27 |
0 |
Premium* |
|
Liquidia Technologies Inc |
LQDA |
10% Owner |
2018-07-30 |
0 |
2018-07-30 |
2,484,870 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
306 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 9 of 13
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
SUPN |
Supernus Pharmaceuticals ... |
Director |
|
2015-06-15 |
4 |
A |
$0.00 |
$0 |
I/I |
1,120,510 |
166,986 |
0 |
- |
|
SUPN |
Supernus Pharmaceuticals ... |
Director |
|
2015-06-16 |
4 |
S |
$16.85 |
$928,668 |
I/I |
(55,105) |
111,881 |
0 |
- |
|
SUPN |
Supernus Pharmaceuticals ... |
Director |
|
2015-06-17 |
4 |
S |
$16.02 |
$1,833,603 |
I/I |
(111,881) |
0 |
0 |
- |
|
VTAE |
Vitae Pharmaceuticals, In... |
10% Owner |
|
2015-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
464 |
464 |
0 |
- |
|
VTAE |
Vitae Pharmaceuticals, In... |
10% Owner |
|
2015-07-01 |
4 |
A |
$0.00 |
$0 |
I/I |
9,384 |
1,134 |
0 |
- |
|
VTAE |
Vitae Pharmaceuticals, In... |
10% Owner |
|
2015-07-01 |
4 |
D |
$0.00 |
$0 |
I/I |
(8,250) |
0 |
0 |
- |
|
VTAE |
Vitae Pharmaceuticals, In... |
10% Owner |
|
2015-07-01 |
4 |
D |
$0.00 |
$0 |
I/I |
(825,000) |
1,786,564 |
0 |
- |
|
SYBX |
Synlogic Inc |
10% Owner |
|
2015-10-05 |
4 |
A |
$0.00 |
$0 |
I/I |
1,825,209 |
2,082,725 |
0 |
- |
|
SYBX |
Synlogic Inc |
10% Owner |
|
2015-10-06 |
4 |
B |
$7.00 |
$5,999,994 |
I/I |
857,142 |
2,971,517 |
1.5 |
- |
|
SYBX |
Synlogic Inc |
10% Owner |
|
2015-10-06 |
4 |
A |
$0.00 |
$0 |
I/I |
289,166 |
2,114,375 |
0 |
- |
|
AVTX |
Avalo Therapeutics, Inc |
10% Owner |
|
2015-10-20 |
4 |
A |
$0.00 |
$0 |
I/I |
594,245 |
594,245 |
0 |
- |
|
SUPN |
Supernus Pharmaceuticals ... |
Director |
|
2015-11-11 |
4 |
D |
$0.00 |
$0 |
I/I |
(4,993,557) |
0 |
0 |
- |
|
SUPN |
Supernus Pharmaceuticals ... |
Director |
|
2015-11-11 |
4 |
A |
$0.00 |
$0 |
D/D |
41,405 |
73,929 |
0 |
- |
|
SUPN |
Supernus Pharmaceuticals ... |
Director |
|
2015-11-11 |
4 |
A |
$0.00 |
$0 |
I/I |
1,426,987 |
212,650 |
0 |
- |
|
SUPN |
Supernus Pharmaceuticals ... |
Director |
|
2015-11-13 |
4 |
S |
$16.26 |
$1,625,610 |
I/I |
(100,000) |
112,650 |
0 |
- |
|
GLYC |
Glycomimetics Inc |
Director |
|
2015-11-16 |
4 |
S |
$6.91 |
$3,123 |
I/I |
(452) |
4,490,751 |
0 |
- |
|
GLYC |
Glycomimetics Inc |
Director |
|
2015-11-16 |
4 |
OE |
$0.33 |
$3,117 |
I/I |
9,445 |
4,491,203 |
0 |
- |
|
SUPN |
Supernus Pharmaceuticals ... |
Director |
|
2015-11-16 |
4 |
S |
$16.13 |
$317,035 |
I/I |
(19,650) |
93,000 |
0 |
- |
|
SUPN |
Supernus Pharmaceuticals ... |
Director |
|
2015-11-17 |
4 |
S |
$16.71 |
$835,460 |
I/I |
(50,000) |
43,000 |
0 |
- |
|
SUPN |
Supernus Pharmaceuticals ... |
Director |
|
2015-11-18 |
4 |
S |
$16.50 |
$709,543 |
I/I |
(43,000) |
0 |
0 |
- |
|
SUPN |
Supernus Pharmaceuticals ... |
Director |
|
2015-11-25 |
4 |
S |
$16.35 |
$264,494 |
D/D |
(16,179) |
73,929 |
0 |
- |
|
SUPN |
Supernus Pharmaceuticals ... |
Director |
|
2015-11-25 |
4 |
OE |
$7.90 |
$137,806 |
D/D |
16,179 |
90,108 |
0 |
- |
|
SUPN |
Supernus Pharmaceuticals ... |
Director |
|
2015-12-03 |
4 |
D |
$0.00 |
$0 |
I/I |
(4,993,557) |
0 |
0 |
- |
|
SUPN |
Supernus Pharmaceuticals ... |
Director |
|
2015-12-03 |
4 |
A |
$0.00 |
$0 |
D/D |
41,426 |
115,355 |
0 |
- |
|
SUPN |
Supernus Pharmaceuticals ... |
Director |
|
2015-12-03 |
4 |
A |
$0.00 |
$0 |
I/I |
1,427,328 |
212,970 |
0 |
- |
|
306 Records found
|
|
Page 9 of 13 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|